Veracyte (VCYT) Net Cash Flow (2012 - 2026)

Veracyte has reported Net Cash Flow for 15 years, with the latest figure at $36.4 million in Q2 2026.

• Net Cash Flow for Q2 2026 came in at $36.4 million, up 10.99% year-over-year; the trailing twelve-month figure through Jun 2026 was $80.0 million (up 592.83% YoY), and the FY2025 annual result was $122.9 million, up 417.92% from the prior year.
• Net Cash Flow improved to $36.4 million in Q2 2026, from -$99.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $96.0 million in Q3 2025 and troughed at -$99.4 million in Q1 2026.
• A 5-year average of $7.1 million and a median of $13.5 million in 2023 frame the typical range for Net Cash Flow.
• The widest annual swing landed in 2023, when Net Cash Flow soared 352.74%; it then plunged 661.51% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$16.6 million in 2022, then soared by 182.55% to $13.7 million in 2023, then tumbled by 349.1% to -$34.1 million in 2024, then surged by 237.73% to $47.0 million in 2025, then retreated by 22.52% to $36.4 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $36.4 million in Q2 2026, -$99.4 million in Q1 2026, and $47.0 million in Q4 2025.